Literature DB >> 9614935

Complement C1q inhibits cellular spreading and stimulates adenylyl cyclase activity of fibroblasts.

X Tan1, S T Wong, B Ghebrehiwet, D R Storm, S Bordin.   

Abstract

C1q selectively localizes at injured tissues, where it may function as a regulator of cell-matrix interactions. We show here that purified C1q, added to the culture medium of human gingival fibroblasts (HF) spread onto fibronectin substrates, elicited a round morphology that was accompanied by altered F-actin and correlated with inhibition of cellular spreading. Shape modification required integrity of the molecule and was specific, dose dependent, nontoxic, and reversible. Antispreading activity was mediated, at least in part, by specific cell-surface C1q receptors. We hypothesized that ligand occupancy of C1q receptors could influence shape by affecting intracellular levels of cyclic AMP (cAMP). Within 20 min of exposure of adhering HF to C1q, we detected an increase in adenylyl cyclase activity (six- to ninefold) in cAMP accumulation (by 20%) and in cAMP-dependent protein kinase activity (by 20%). These changes suggested that the rounding effect of C1q may be associated with activation of the adenylyl cyclase pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614935     DOI: 10.1006/clin.1997.4485

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  2 in total

1.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

2.  Is the A-Chain the Engine That Drives the Diversity of C1q Functions? Revisiting Its Unique Structure.

Authors:  Berhane Ghebrehiwet; Evelyn Kandov; Uday Kishore; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.